BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 12615720)

  • 1. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
    Kennedy RC; Shearer MH; Watts AM; Bright RK
    Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization.
    Lowe DB; Shearer MH; Tarbox JA; Kang HS; Jumper CA; Bright RK; Kennedy RC
    Virology; 2005 Feb; 332(1):28-37. PubMed ID: 15661138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
    J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity in BALB/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes.
    Zerrahn J; Utermöhlen O; Warnecke G; Deppert W; Lehmann-Grube F
    J Immunol; 1996 May; 156(10):3919-24. PubMed ID: 8621931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.
    Aldrich JF; Shearer MH; Lowe DB; Winn RE; Jumper CA; Kennedy RC; Bright RK
    Cancer Immunol Immunother; 2013 Feb; 62(2):371-82. PubMed ID: 22926061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
    Shearer MH; Bright RK; Kennedy RC
    Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
    Newmaster RS; Mylin LM; Fu TM; Tevethia SS
    Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunity.
    Kennedy RC; Shearer MH; Lowe DB; Jumper CA; Chiriva-Internati M; Bright RK
    Cancer Immunol Immunother; 2004 Nov; 53(11):987-94. PubMed ID: 15156293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase.
    Lowe DB; Shearer MH; Jumper CA; Bright RK; Kennedy RC
    J Virol; 2010 Jan; 84(2):883-93. PubMed ID: 19889780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of SV40 induced tumours in mice: a model for vaccine development.
    Bright RK; Shearer MH; Pass HI; Kennedy RC
    Dev Biol Stand; 1998; 94():341-53. PubMed ID: 9776255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4- CD8+ cytotoxic T lymphocytes in mice.
    Schirmbeck R; Zerrahn J; Kuhröber A; Kury E; Deppert W; Reimann J
    Eur J Immunol; 1992 Mar; 22(3):759-66. PubMed ID: 1312473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen.
    Bright RK; Beames B; Shearer MH; Kennedy RC
    Cancer Res; 1996 Mar; 56(5):1126-30. PubMed ID: 8640771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with adenoviral vectors carrying recombinant IL-12 and E7 enhanced the antitumor immunity to human papillomavirus 16-associated tumor.
    Jin HS; Park EK; Lee JM; NamKoong SE; Kim DG; Lee YJ; Jun HJ; Han BD; Bae SM; Ahn WS
    Gynecol Oncol; 2005 May; 97(2):559-67. PubMed ID: 15863160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hosts.
    den Boer AT; van Mierlo GJ; Fransen MF; Melief CJ; Offringa R; Toes RE
    Cancer Res; 2005 Aug; 65(15):6984-9. PubMed ID: 16061684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-4 impairs granzyme-mediated cytotoxicity of Simian virus 40 large tumor antigen-specific CTL in BALB/c mice.
    Baschuk N; Utermöhlen O; Gugel R; Warnecke G; Karow U; Paulsen D; Brombacher F; Krönke M; Deppert W
    Cancer Immunol Immunother; 2007 Oct; 56(10):1625-36. PubMed ID: 17431618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive transfer enables tumor rejection targeted against a self-antigen without the induction of autoimmunity.
    Eck SC; Turka LA
    Cancer Res; 2001 Apr; 61(7):3077-83. PubMed ID: 11306490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes.
    Mylin LM; Schell TD; Roberts D; Epler M; Boesteanu A; Collins EJ; Frelinger JA; Joyce S; Tevethia SS
    J Virol; 2000 Aug; 74(15):6922-34. PubMed ID: 10888631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.
    Takeshita K; Yamasaki T; Akira S; Gantner F; Bacon KB
    Int Immunol; 2004 May; 16(5):685-95. PubMed ID: 15096484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA.
    Aldrich JF; Lowe DB; Shearer MH; Winn RE; Jumper CA; Bright RK; Kennedy RC
    J Virol; 2011 Jul; 85(14):7216-24. PubMed ID: 21593176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.